Skip to content

Medications used to induce labor

Sequential Use Of Mifepristone, Dinoprostone And Misoprostol For Induction Of Labor - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/058260
Enrollment
200
Registered
2023-10-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery

Interventions

Intervention1: Sequential use of Mifepristone, Dinoprostone And Misoprostol For induction of labor: Day(cycle) 1- Single dose of Mifepristone 200MG P/O • Day(cycle) 2- Single dose of Dinoprostone gel

Sponsors

Dr Asmita Yadav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Singleton, live gestation • Primi and Multigravida • Gestational age between 37 weeks 0 days - 42 weeks 0 days • Fetus in cephalic presentation • Patients admitted for labor induction • Patients who are not in labor with intact membranes • Patients with no contraindication for vaginal delivery

Exclusion criteria

Exclusion criteria: Significant cardiac, renal, or hepatic maternal comorbidities, severe gestational hypertension or preeclampsia with severe features ? Pregnancies complicated by major fetal anomalies ? Pregnancies complicated by fetal growth restriction (Estimated fetal weight <10%) ? Fetuses with an estimated fetal weight >4500 gm by recent ultrasound or Leopold's exam on admission ? Any indication for scheduled cesarean delivery ? Hypersensitivity to prostaglandins

Design outcomes

Primary

MeasureTime frame
vaginal & Caesarean delivery rates with each sequential cycleTimepoint: Day 1 Day 2 Day 3

Secondary

MeasureTime frame
To evaluate maternal (Intrapartum chorionamnionitis, Post partum hemorrhage rates, ICU admissions) and perinatal outcomes (Birth weight, APGAR scores, Meconium stained amniotic fluid, NICU admissions) with sequential cycles of above mentioned agentsTimepoint: Day 1 Day 2 Day 3

Countries

India

Contacts

Public ContactDr. Rajani Upadhyaya

Kasturba Medical College, Manipal

Shripad.hebbar@manipal.edu9611786463

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026